Teva Pharmaceutical Industries Ltd.

Petach Tikva

Trademarks

More trademarks (39)
TACFORIUS

No. 699342 · Class 5

protected until Nov 29, 2026
TACFORAN

No. 699343 · Class 5

protected until Nov 29, 2026
LADOVIQ

No. 696610 · Class 5

protected until Sep 8, 2026
AVACNI

No. 690245 · Class 5

protected until Apr 12, 2026
TACVANCE

No. 688780 · Class 5

protected until Apr 8, 2026
TACNIXEL

No. 688781 · Class 5

protected until Apr 8, 2026
TACNITARD

No. 688782 · Class 5

protected until Apr 8, 2026
teva

No. 693067 · Classes 1, 3, 5, 9, 10, 16, 35, 42, 44

protected until Mar 22, 2036
Figurative mark

No. 689733 · Classes 5, 10, 42

protected until Mar 22, 2036
VIBOVIT

No. 688707 · Classes 5, 30

protected until Mar 7, 2036
TEVAGUARD

No. 668183 · Class 17

protected until Oct 23, 2034
TACNI XL

No. 610416 · Class 5

protected until Sep 17, 2030
TEVA BIOPHARMACEUTICALS

No. 578750 · Class 5

protected until Jun 25, 2028
TACNI

No. 573922 · Class 5

protected until Apr 30, 2028
COMPASS GLOBAL MS NURSE JOURNAL

No. 573432 · Class 16

protected until Apr 10, 2028
COMPASS GLOBAL MS NURSE JOURNAL

No. 573433 · Class 16

protected until Apr 10, 2028
TEVA

No. 458878 · Class 5

protected until Sep 2, 2028
COPAXONE

No. 404505 · Class 5

protected until Dec 31, 2032
TEVA

No. 384210 · Class 5

protected until Aug 16, 2030
teva

International registration 1829733 · Class 5

Weniger Migräne. Mehr erleben

Application 01609/2019 · Classes 16, 44

deleted Apr 25, 2020
Moins de migraine pour vivre mieux

Application 00547/2019 · Classes 16, 44

deleted Apr 25, 2020
Weniger Migräne. Mehr vom Leben.

Application 00548/2019 · Classes 16, 44

deleted Apr 25, 2020
Meno emicranie per una miglior qualità di vita.

Application 77277/2018 · Classes 16, 41

deleted Sep 9, 2020
IVAMOD

No. 696611 · Class 5

deleted May 10, 2017
TEVABONE

No. 592872 · Class 5

deleted Jan 28, 2020
PACLITAXEL-TEVA

No. 451416 · Class 5

deleted Jul 14, 2008
TACTROL

No. 421055 · Class 5

deleted Oct 11, 2024
RODOMEL

No. 421056 · Class 5

deleted Oct 2, 1996
PEXRIL

No. 421057 · Class 5

deleted Dec 6, 2004
CATADEC

No. 421058 · Class 5

deleted Oct 11, 2024
PERZIRON

No. 421059 · Class 5

deleted Dec 6, 2004
BONDIOL

No. 412885 · Class 5

deleted Feb 10, 2014
TEVA RONIDEX

No. 404928 · Class 5

deleted Aug 19, 2013
COPAZONE

No. 404506 · Class 5

deleted Aug 5, 2013
OSTEOD

No. 384209 · Class 5

deleted May 31, 1994
EGRANLI

International registration 1105365 · Class 5

ALAZMIA

International registration 1105366 · Class 5

DURGRANIN

International registration 1105368 · Class 5

Holder of 49 trademarks, 30 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property. The register names a holder by name and address only, so a mark is listed here when its holder’s name is this entity’s.

Designs

Holder of 4 design registrations, 0 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property. A design is listed here when its holder’s name is this entity’s.

Patents

More trademarks (40)
NILOTINIB SALZE UND DEREN KRISTALLINE FORMEN

EP2571863

Deleted
RALTEGRAVIRSALZE UND KRISTALLINE FORMEN DAVON

EP2545048

Deleted
Kristalline Raltegravir-Natriumsalze

EP2796458

Deleted
BEHANDLUNG VON LUPUS NEPHRITIS MIT LAQUINIMOD

EP2542078

Deleted
BEHANDLUNG RHEUMATOIDER ARTHRITIS MIT EINER KOMBINATION AUS LAQUINIMOD UND METHOTREXAT

EP2542079

Deleted
BEHANDLUNG VON LUPUS ARTHRITIS MIT LAQUINIMOD

EP2542080

Deleted
BEHANDLUNG VON MORBUS CROHN MIT LAQUINIMOD

EP2458992

Deleted
PERINDOPRILTOSYLAT

EP2367791

Deleted
BEHANDLUNG MULTIPLER SKLEROSE MIT LAQUINIMOD

EP2442651

Deleted
KRISTALLINE FORMEN VON FEBUXOSTAT

EP2398784

Deleted
PROGRAMMIERBARE KONDENSATABLEITERVORRICHTUNG

EP2414722

Deleted
Formulierung von Glatirameracetat mit verringertem Volumen und Verabreichungsverfahren

EP2275086

Deleted
Rasagilinformulierung mit verzögerter Freisetzung

EP2246321

Deleted
Rasagilinformulierung mit verzögerter Freisetzung

EP2308477

Deleted
RASAGILINFORMULIERUNG MIT VERZÖGERTER FREISETZUNG

EP2381767

Deleted
KRISTALLINE FORMEN VON NILOTINIB HCI

EP2262793

Deleted
2-OXO-1,2-DIHYDRO-CHINOLIN-MODULATOREN DER IMMUNFUNKTION

EP2337779

Deleted
RASAGILIN-WEICHGELATINEKAPSELN

EP2285214

Deleted
VERFAHREN ZUR HERSTELLUNG VON SUNITINIB UND SALZEN DAVON

EP2274303

Deleted
STABILE LAQUINIMOD-PRÄPARATE

EP2234485

Deleted
Stabile Laquinimod-Präparate

EP2682120

Deleted
Dasatinib-Polymorphe und Verfahren zu ihrer Herstellung

EP2508523

Deleted
TOPISCHE VERWENDUNG VON R(+)-N-PROPARGYL-1-AMINOINDAN ZUR BEHANDLUNG ODER VORBEUGUNG VON GEHÖRVERLUST

EP2203050

Deleted
PALIPERIDONFORMULIERUNG MIT VERZÖGERTER FREISETZUNG

EP2079446

Deleted
Feste Dosierformen

EP1985310

Deleted
Verfahren zur Herstellung von Zwiechenverbindungen von HMG-CoA reductase Inhibitoren

EP2172471

Deleted
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT CANDESARTAN-CILEXETIL

EP2019668

Deleted
SPRITZE MIT EINEM SPRITZENETIKETT

EP1946787

Deleted
KRISTALLINE FESTE RASAGILIN-BASE

EP2101569

Deleted
RASAGILIN-TANNAT

EP2101570

Deleted
VERFAHREN ZUR HERSTELLUNG EINER CINACALCETBASE

EP1915335

Deleted
TIGECYCLINKRISTALLINE FORM UND HERSTELLUNGSVERFAHREN DAFÜR

EP2016045

Deleted
Kristalline Tigecylinformen und Verfahren zur Herstellung davon

EP2857386

Deleted
VERWENDUNG VON RASAGILIN ZUR BEHANDLUNG VON MULTIPLER SYSTEMATROPHIE

EP1991214

Deleted
VERFAHREN ZUR ISOLIERUNG PROPARGYLIERTER AMINOINDANE

EP1954667

Deleted
KRISTALLE VON LAQUINIMOD-NATRIUM UND VERFAHREN ZU DEREN HERSTELLUNG

EP1937642

Deleted
ASYMMETRISCHE SYNTHESE VON (S)-(+)-3-(AMINOMETHYL)-5-METHYLHEXANSÄURE

EP1841726

Deleted
FESTES, TEILCHENFÖRMIGES TADALAFIL MIT BIMODALER TEILCHENGRÖSSENVERTEILUNG

EP1843770

Deleted
Stabile Zubereitung enthaltend eine Kombination aus einer feuchtigkeitsempfindlichen aktiven Substanz und einer zweiten aktiven Substanz und Verfahren zur Herstellung der Zubereitung

EP1889629

Deleted
REINIGUNG VON MONTELUKAST

EP1904448

Deleted

Holder of 151 patents, 3 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.